173 related articles for article (PubMed ID: 17259800)
1. Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying.
Bartalena L; Tanda ML
J Endocrinol Invest; 2006 Dec; 29(11):1012-6. PubMed ID: 17259800
[No Abstract] [Full Text] [Related]
2. [Novel treatment opportunities in Graves' orbitopathy].
Erdei A; Gazdag A; Bodor M; Berta E; Katkó M; Ujhelyi B; Steiber Z; Győry F; Urbancsek H; Barna S; Galuska L; Nagy VE
Orv Hetil; 2014 Aug; 155(33):1295-300. PubMed ID: 25109914
[TBL] [Abstract][Full Text] [Related]
3. [Biological treatment options for Graves' ophthalmopathy].
El Fassi D; Nielsen CH; Hegedüs L
Ugeskr Laeger; 2008 Jun; 170(24):2128-30. PubMed ID: 18565294
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies in neurology].
Jedidi Z; Jedidi H; Moonen G; Belachew S
Rev Med Liege; 2009; 64(5-6):305-9. PubMed ID: 19642464
[TBL] [Abstract][Full Text] [Related]
5. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
Genere N; Stan MN
Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies in dermatological practice].
Rudnicka L; Szymańska E; Oledzka E; Olszewska M
Pol Merkur Lekarski; 2005 Dec; 19(114):839-42. PubMed ID: 16521437
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Gonzales M; Fratianni C; Mamillapali C; Khardori R
Med Clin North Am; 2012 May; 96(3):635-54, xi. PubMed ID: 22703859
[TBL] [Abstract][Full Text] [Related]
8. [Anti-cytokine therapy for connective tissue disease].
Hayashi T; Goto D; Sumida T
Nihon Rinsho; 2005 May; 63 Suppl 5():233-9. PubMed ID: 15954355
[No Abstract] [Full Text] [Related]
9. Immunotherapies in dermatologic disorders.
Fallen RS; Terpstra CR; Lima HC
Med Clin North Am; 2012 May; 96(3):565-82, x-xi. PubMed ID: 22703856
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic monoclonal antibodies in ophthalmology.
Rodrigues EB; Farah ME; Maia M; Penha FM; Regatieri C; Melo GB; Pinheiro MM; Zanetti CR
Prog Retin Eye Res; 2009 Mar; 28(2):117-44. PubMed ID: 19114125
[TBL] [Abstract][Full Text] [Related]
11. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).
Graves JE; Nunley K; Heffernan MP
J Am Acad Dermatol; 2007 Jan; 56(1):e55-79. PubMed ID: 17190618
[TBL] [Abstract][Full Text] [Related]
12. [Anti-cytokine and anti-lymphocyte monoclonal antibodies in the treatment of thyroid associated ophthalmopathy].
Komorowski J; Jankiewicz-Wika J; Siejka A; Lawnicka H; Stepień H
Pol Merkur Lekarski; 2007 Jun; 22(132):571-4. PubMed ID: 17874632
[TBL] [Abstract][Full Text] [Related]
13. [Immune mechanisms and novel therapeutic targets for ITP].
Kuwana M; Ikeda Y
Rinsho Ketsueki; 2005 Feb; 46(2):99-103. PubMed ID: 16447702
[No Abstract] [Full Text] [Related]
14. Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance.
Wailoo A; Bansback N; Chilcott J
Rheumatology (Oxford); 2008 Feb; 47(2):119-20. PubMed ID: 18208819
[No Abstract] [Full Text] [Related]
15. [Proteins support stem cells - use of protein therapeutics in hematopoietic stem cell transplantation].
Meyer SC; Stern M
Ther Umsch; 2011 Nov; 68(11):641-9. PubMed ID: 22045526
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for Graves' ophthalmopathy.
Salvi M
Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):409-14. PubMed ID: 25105999
[TBL] [Abstract][Full Text] [Related]
17. Molecularly targeted therapies for dysimmune neuropathies.
Argyriou AA
Mol Med; 2009; 15(7-8):283-7. PubMed ID: 19593413
[TBL] [Abstract][Full Text] [Related]
18. [Biologics in skin diseases other than psoriasis].
Gniadecki R; Skov L
Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
[TBL] [Abstract][Full Text] [Related]
19. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
Thyroid; 2006 Jul; 16(7):709-10. PubMed ID: 16889501
[No Abstract] [Full Text] [Related]
20. [Biological therapy treatment of juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2008 Jun; 170(24):2105-8. PubMed ID: 18565289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
